European Pharmaceutical 2013 Salary Survey

Do you earn the correct amount? As part of the Clinical Professionals Group, Only Medics are launching a European salary survey to determine the salary and benefits for European pharmaceutical physicians. The salary survey consists of questions concerning your career and how satisfied you are with your current salary, and will only take a few minutes to

Continue Reading

AstraZeneca Acquires AlphaCore Pharma

AstraZeneca have today announced that they are expanding their cardiovascular and metabolic disease pipeline with the acquisition of AlphaCore Pharma. AlphaCore are a Michigan-based biotechnology company focused on the development of ACP-501, a recombinant human lecithin-cholesterol acyltransferase (LCAT) enzyme. AstraZeneca’s MedImmune unit is buying privately-held AlphaCore primarily because of ACP-501.  AstraZeneca note that LCAT is

Continue Reading

Cancer Research Technology, the Institute of Cancer Research and Janssen Partner for Myeloma Drug

Cancer Research Technology (CRT) and the Institute of Cancer Research (ICR) announced earlier today that they have partnered with Johnson & Johnson unit, Janssen Biotech, in an agreement to discover a potential new drug for the blood cancer, multiple myeloma. The partnership is aiming to identify molecules and develop them into experimental therapies that block

Continue Reading

Only Medics to Attend DGPharMed 2013

Only Medics will be attending DGPharMed’s annual conference at the Hotel Concorde, Berlin, Germany on the 14th and 15th March 2012. 2013 sees the 29th year of the annual conference by the German Society of Pharmaceutical Medicine. The conference starts at 9:20am, and finishes the following day.  The topic of this year’s conference will be

Continue Reading

Only Medics Relocate to New UK Office!

As part of our continued expansion, Only Medics have relocated to a new larger UK office, having outgrown our previous office. The new office is over double the size of the previous UK office, allowing Only Medics to continue growing to fit your future needs. Our new office is located at: 1st Floor 33 Blagrave

Continue Reading

Only Medics to Attend the 2013 BrAPP Conference

Only Medics will be attending this year’s BrAPP Annual Symposium on 7th March 2013 in Royal College of Pathologists. The conference will start at 9am, and will conclude at 5pm with the BrAPP AGM for BrAPP members. The conference offers attendees the chance to opportunity to network with fellow pharmaceutical physicians, speakers and other colleagues.

Continue Reading

Warner Chilcott Q4 Net Income Increases 37.8%

Warner Chilcott has announced that their fourth-quarter net income grew 37.8%, although pharmaceutical sales were hit by the impact of generic competition for their osteoporosis drug, Actonel. The organisation’s net income increased to $124 million, or 49 cents per share, up from $90 million, or 36 cents per share.  The company’s revenue dropped 5%, to

Continue Reading

CROMSOURCE Expands in Poland

CROMSOURCE, which was formed roughly two years ago as a result of the acquisition of MSOURCE by CROM, has combined it’s presence in Poland with a new office in Warsaw. When CROM acquired MSOURCE, the latter contract research organisation (CRO) had been internationally active since 1994. Dr Oriana Zerbini, chief executive officer of CROMSOURCE, commented

Continue Reading